デフォルト表紙
市場調査レポート
商品コード
1427958

医薬品充填と仕上げアウトソーシングの世界市場レポート 2024年

Pharmaceutical Fill and Finish Outsourcing Global Market Report 2024

出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 175 Pages | 納期: 2~10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.89円
医薬品充填と仕上げアウトソーシングの世界市場レポート 2024年
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2~10営業日
  • 全表示
  • 概要
  • 目次
概要

医薬品充填と仕上げアウトソーシングの市場規模は、今後数年間で大幅な成長が見込まれています。 2028年には7.8%の年間複合成長率(CAGR)で47億3,000万米ドルに成長すると予想されます。予測期間中に予想される成長は、専門サービスに対する継続的な需要、世界の市場拡大の取り組み、製薬会社の中核的能力への注力、新薬の迅速な市場参入への欲求、と製薬会社が提供する柔軟性などの要因に起因すると考えられます。変動に対応するためのアウトソーシング製造能力。予測期間中に予想される注目すべき動向には、生物製剤のアウトソーシングの増加、医薬品製造部門における持続可能性への取り組み、アウトソーシングハブの地理的拡大、効率向上のための技術の統合、と受託開発と製造組織の普及の増加が含まれます。

予想される生物学的製剤の需要の増加により、医薬品充填と仕上げアウトソーシング市場の成長が促進される見込みです。生物製剤またはバイオシミラーとしても知られる生物製剤は、生体に由来する、または生体の成分を含む医薬品の一種を構成します。生産プロセスを合理化するために、製薬メーカーは多くの場合、充填と仕上げの段階をアウトソーシングすることで受託製造組織(CMO)の専門知識とインフラストラクチャを活用します。この戦略的アプローチにより、製薬会社は効率的で費用対効果の高い充填と仕上げ業務をCMOに頼って、生物製剤の開発、調査、スケールアップに集中することができます。特に、2022年9月、アクセシブル医薬品協会(AAM)は、2021年に米国で処方された64億件のうち91%がジェネリック医薬品とバイオシミラー医薬品であり、年間3,730億米ドルを超える節約効果があったと報告しました。これは、生物製剤に対する需要の高まりを浮き彫りにしており、それによって医薬品充填と仕上げアウトソーシング市場を牽引しています。

バイオ医薬品への研究開発(R&D)投資の大幅な増加は、医薬品充填と仕上げアウトソーシング市場の拡大に貢献する重要な原動力です。研究開発投資とは、新しいバイオ医薬品の発見、開発、市場への導入に重点を置いた活動に割り当てられる資金を指します。製薬会社がイノベーションと医薬品開発への重点を強化する中、充填と仕上げサービスをアウトソーシングすることで、リソースと投資を中核となる研究開発活動に振り向けることができます。英国では、政府が2020年に医薬品の研究開発に189億米ドル(153億ポンド)を支出し、2022年から2025年までに492億米ドル(398億ポンド)の予算配分を行うと発表しました。さらに、Roche Holding AGは、2022年の研究開発支出が2021年と比較して3.7%増加することを明らかにしました。その結果、バイオ医薬品企業による研究開発への投資の増加が医薬品充填と仕上げアウトソーシング市場の触媒として機能しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界市場規模と成長

  • 世界の医薬品充填と仕上げアウトソーシング市場の促進要因と抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 世界の医薬品充填と仕上げアウトソーシングの市場規模実績と成長、2018~2023年
  • 世界の医薬品充填と仕上げアウトソーシング市場規模と成長予測、2023~2028年、2033年

第6章 市場セグメンテーション

  • 世界の医薬品充填と仕上げアウトソーシング市場、完成品の状態別セグメンテーション、実績と予測、2018~2023年、2023~2028年、2033年
  • 液体
  • 固体
  • 半固体
  • 世界の医薬品充填と仕上げアウトソーシング市場、内容別セグメンテーション、実績と予測、2018~2023年、2023~2028年、2033年
  • 動物由来の有機物質
  • 微生物由来の有機物質
  • 無機物質
  • 世界の医薬品充填と仕上げアウトソーシング市場、エンドユーザー別セグメンテーション、実績と予測、2018~2023年、2023~2028年、2033年
  • バイオ医薬品企業
  • 製薬会社

第7章 地域と国の分析

  • 世界の医薬品充填と仕上げアウトソーシング市場、地域別、実績と予測、2018~2023年、2023~2028年、2033年
  • 世界の医薬品充填と仕上げアウトソーシング市場、国別、実績と予測、2018~2023年、2023~2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 医薬品充填と仕上げアウトソーシング市場の競合情勢
  • 医薬品充填と仕上げアウトソーシング市場の企業プロファイル
    • Groninger and Co. GmbH
    • Merck and Co. Inc.
    • Abbott Laboratories
    • Wockhardt Limited.
    • Boehringer Ingelheim International GmbH

第31章 その他の大手と革新的な企業

  • Becton Dickinson and Company
  • AbbVie Inc.
  • Teva Pharmaceuticals Industries Ltd.
  • Recipharm AB.
  • Lonza Group AG
  • Catalent Inc.
  • Dr. Reddys Laboratories Ltd.
  • West Pharmaceutical Services Inc.
  • Sun Pharmaceutical Industries Ltd.
  • Patheon NV
  • Piramal Enterprises Ltd.
  • Gerresheimer AG
  • CordenPharma International
  • Fujifilm Diosynth Biotechnologies
  • Optima Packaging Group GmbH

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の展望と潜在性分析

第36章 付録

目次
Product Code: r13802

Pharmaceutical fill and finish outsourcing involves the practice of contracting with specialized pharmaceutical manufacturing companies to provide services related to pharmaceutical filling and sealing operations into end-use containers with the required sterility and accuracy. This outsourcing is employed by pharmaceutical and biopharmaceutical companies to leverage specialized expertise, avoid the high costs associated with acquiring automated equipment, meet stringent regulatory agency standards, enhance efficiency, and gain flexibility in terms of production capacity.

The primary types of pharmaceutical fill and finish outsourcing products are liquids, solids, and semi-solids. Liquids refer to pharmaceutical formulations that are pourable and consist of a combination of active drug or chemical components and inert components. These formulations may be processed from organic substances isolated from animal origin, organic substances isolated from microorganisms, and inorganic substances. Pharmaceutical and biopharmaceutical companies commonly utilize these outsourcing services for their production needs.

The pharmaceutical fill and finish outsourcing market research report is one of a series of new reports from The Business Research Company that provides pharmaceutical fill and finish outsourcing market statistics, including pharmaceutical fill and finish outsourcing industry global market size, regional shares, competitors with a pharmaceutical fill and finish outsourcing market share, detailed pharmaceutical fill and finish outsourcing market segments, market trends and opportunities, and any further data you may need to thrive in the pharmaceutical fill and finish outsourcing industry. This pharmaceutical fill-and-finish outsourcing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The pharmaceutical fill and finish outsourcing market size has grown strongly in recent years. It will grow from $3.25 billion in 2023 to $3.51 billion in 2024 at a compound annual growth rate (CAGR) of 7.8%. The growth observed in the historical period can be attributed to several factors, including the emergence of Contract Development and Manufacturing Organizations (CDMOs), the increased demand for specialized services, a shift towards outsourced models, market expansion strategies, and the need to meet stringent regulatory requirements.

The pharmaceutical fill and finish outsourcing market size is expected to see strong growth in the next few years. It will grow to $4.73 billion in 2028 at a compound annual growth rate (CAGR) of 7.8%. The anticipated growth in the forecast period can be attributed to factors such as the continued demand for specialized services, global market expansion initiatives, a focus on core competencies by pharmaceutical companies, the desire for rapid market entry for new drugs, and the flexibility offered by outsourced manufacturing capacity to accommodate fluctuations. Noteworthy trends expected in the forecast period encompass an increase in biologics outsourcing, sustainability initiatives in the pharmaceutical manufacturing sector, the geographic expansion of outsourcing hubs, the integration of technology for enhanced efficiency, and a rise in the prevalence of Contract Development and Manufacturing Organizations (CDMOs).

The anticipated increase in demand for biologic drugs is poised to drive the growth of the pharmaceutical fill and finish outsourcing market. Biologic drugs, also known as biologics or biosimilars, constitute a class of pharmaceutical products derived from living organisms or containing components of living organisms. To streamline production processes, drug manufacturers often leverage the expertise and infrastructure of contract manufacturing organizations (CMOs) through outsourcing the fill and finish phase. This strategic approach allows pharmaceutical companies to concentrate on the development, research, and scale-up of their biologic drugs, relying on CMOs for efficient and cost-effective fill and finish operations. Notably, in September 2022, the Association for Accessible Medicines (AAM) reported that 91% of the 6.4 billion prescriptions in the United States in 2021 were generic and biosimilar medications, yielding annual savings exceeding $373 billion. This underscores the escalating demand for biologic drugs, thereby driving the pharmaceutical fill and finish outsourcing market.

The significant upswing in research and development (R&D) investments in biopharmaceuticals is a key driver contributing to the expansion of the pharmaceutical fill and finish outsourcing market. R&D investments denote financial resources allocated to activities focused on discovering, developing, and introducing new biopharmaceutical products to the market. As pharmaceutical companies intensify their emphasis on innovation and drug development, the outsourcing of fill and finish services allows them to redirect resources and investments towards core R&D activities. In the UK, the government announced a spending of $18.9 billion (£15.3bn) on pharmaceutical R&D in 2020, with a budget allocation of $49.2 billion (£39.8 bn) for the years 2022-2025. Additionally, Roche Holding AG revealed a 3.7% increase in its R&D expenditure for 2022 compared to 2021. Consequently, heightened investments in research and development by biopharmaceutical companies are acting as a catalyst for the pharmaceutical fill and finish outsourcing market.

A noteworthy trend gaining prominence in the pharmaceutical fill and finish outsourcing market is the integration of AI-driven tools. Companies within this market are embracing new technologies, particularly AI solutions, to enhance patient outcomes and maintain a competitive edge. For instance, Carenostics, a US-based healthcare startup specializing in AI solutions, introduced a product designed to analyze electronic health record (EHR) data for the early identification of chronic kidney disease (CKD). The seamless integration of AI-powered clinical decision support models into healthcare providers' EHR systems empowers clinicians to accurately identify high-risk patients with chronic diseases, facilitating proactive measures for improved patient outcomes.

Major companies in the pharmaceutical fill and finish outsourcing market are adopting a strategic partnership approach to enhance patient care, drive innovation, and expedite the commercialization of therapies. Southern California Kidney Consultants Inc., a US-based medical practices company, recently partnered with Strive Health, a US-based healthcare company, with the goal of improving kidney disease treatment and care. This collaboration involves 21 providers primarily based in Orange County, serving 5,000 patients with chronic kidney disease (CKD) and end-stage renal disease (ESRD).

In January 2023, AstraZeneca Pharmaceuticals LP, a US-based biopharmaceutical company, completed the acquisition of CinCor Pharma Inc. for $1.8 billion. This strategic move allows AstraZeneca to strengthen its cardiorenal portfolio by incorporating CinCor's promising compound, baxdrostat (CIN-107). Baxdrostat, an aldosterone synthase inhibitor (ASI), is designed to lower blood pressure in patients with treatment-resistant hypertension, including those with chronic kidney disease. CinCor Pharma Inc. is a US-based clinical-stage biopharmaceutical company specializing in kidney disease medications and treatments.

Major companies operating in the pharmaceutical fill and finish outsourcing market report are Groninger and Co. GmbH, Merck and Co. Inc., Abbott Laboratories, Wockhardt Limited., Boehringer Ingelheim International GmbH, Becton Dickinson and Company, AbbVie Inc., Teva Pharmaceuticals Industries Ltd., Recipharm AB., Lonza Group AG, Catalent Inc., Dr. Reddy's Laboratories Ltd., West Pharmaceutical Services Inc., Sun Pharmaceutical Industries Ltd., Patheon N.V., Piramal Enterprises Ltd., Gerresheimer AG, CordenPharma International, Fujifilm Diosynth Biotechnologies, Optima Packaging Group GmbH, Jubilant HollisterStier LLC., Ajinomoto Bio-Pharma Services, Cytovance Biologics Inc., Grand River Aseptic Manufacturing, Baxter Pharmaceutical Solutions LLC., Halo Pharma Inc., MabPlex Inc., August Bioservices, Syntegon Technology GmbH (Robert Bosch GmbH), Ranbaxy Laboratories Limited.

North America was the largest region in the pharmaceutical fill and finish outsourcing market in 2023. The regions covered in the pharmaceutical fill and finish outsourcing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the pharmaceutical fill and finish outsourcing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The pharmaceutical fill and finish outsourcing market includes revenues earned by entities by providing outsourcing of aseptic or sterile filling and finishing services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Pharmaceutical Fill and Finish Outsourcing Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on pharmaceutical fill and finish outsourcing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for pharmaceutical fill and finish outsourcing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The pharmaceutical fill and finish outsourcing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By State Of Finished Products: Liquid; Solids; Semi Solids
  • 2) By Content: Organic Substances Isolated From Animal Origin; Organic Substances Isolated From Microorganisms; Inorganic Substances
  • 3) By End-Users: Biopharmaceutical Companies; Pharmaceutical Companies
  • Companies Mentioned: Groninger and Co. GmbH; Merck and Co. Inc.; Abbott Laboratories; Wockhardt Limited.; Boehringer Ingelheim International GmbH
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Pharmaceutical Fill and Finish Outsourcing Market Characteristics

3. Pharmaceutical Fill and Finish Outsourcing Market Trends And Strategies

4. Pharmaceutical Fill and Finish Outsourcing Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Pharmaceutical Fill and Finish Outsourcing Market Size and Growth

  • 5.1. Global Pharmaceutical Fill and Finish Outsourcing Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Pharmaceutical Fill and Finish Outsourcing Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Pharmaceutical Fill and Finish Outsourcing Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Pharmaceutical Fill and Finish Outsourcing Market Segmentation

  • 6.1. Global Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By State Of Finished Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Liquid
  • Solids
  • Semi Solids
  • 6.2. Global Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By Content, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Organic Substances Isolated From Animal Origin
  • Organic Substances Isolated From Microorganisms
  • Inorganic Substances
  • 6.3. Global Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Biopharmaceutical Companies
  • Pharmaceutical Companies

7. Pharmaceutical Fill and Finish Outsourcing Market Regional And Country Analysis

  • 7.1. Global Pharmaceutical Fill and Finish Outsourcing Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Pharmaceutical Fill and Finish Outsourcing Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Pharmaceutical Fill and Finish Outsourcing Market

  • 8.1. Asia-Pacific Pharmaceutical Fill and Finish Outsourcing Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By State Of Finished Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By Content, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Pharmaceutical Fill and Finish Outsourcing Market

  • 9.1. China Pharmaceutical Fill and Finish Outsourcing Market Overview
  • 9.2. China Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By State Of Finished Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By Content, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Pharmaceutical Fill and Finish Outsourcing Market

  • 10.1. India Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By State Of Finished Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By Content, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Pharmaceutical Fill and Finish Outsourcing Market

  • 11.1. Japan Pharmaceutical Fill and Finish Outsourcing Market Overview
  • 11.2. Japan Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By State Of Finished Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By Content, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Pharmaceutical Fill and Finish Outsourcing Market

  • 12.1. Australia Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By State Of Finished Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By Content, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Pharmaceutical Fill and Finish Outsourcing Market

  • 13.1. Indonesia Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By State Of Finished Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By Content, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Pharmaceutical Fill and Finish Outsourcing Market

  • 14.1. South Korea Pharmaceutical Fill and Finish Outsourcing Market Overview
  • 14.2. South Korea Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By State Of Finished Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By Content, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Pharmaceutical Fill and Finish Outsourcing Market

  • 15.1. Western Europe Pharmaceutical Fill and Finish Outsourcing Market Overview
  • 15.2. Western Europe Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By State Of Finished Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By Content, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Pharmaceutical Fill and Finish Outsourcing Market

  • 16.1. UK Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By State Of Finished Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By Content, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Pharmaceutical Fill and Finish Outsourcing Market

  • 17.1. Germany Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By State Of Finished Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By Content, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Pharmaceutical Fill and Finish Outsourcing Market

  • 18.1. France Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By State Of Finished Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By Content, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Pharmaceutical Fill and Finish Outsourcing Market

  • 19.1. Italy Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By State Of Finished Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By Content, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Pharmaceutical Fill and Finish Outsourcing Market

  • 20.1. Spain Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By State Of Finished Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By Content, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Pharmaceutical Fill and Finish Outsourcing Market

  • 21.1. Eastern Europe Pharmaceutical Fill and Finish Outsourcing Market Overview
  • 21.2. Eastern Europe Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By State Of Finished Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By Content, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Pharmaceutical Fill and Finish Outsourcing Market

  • 22.1. Russia Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By State Of Finished Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By Content, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Pharmaceutical Fill and Finish Outsourcing Market

  • 23.1. North America Pharmaceutical Fill and Finish Outsourcing Market Overview
  • 23.2. North America Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By State Of Finished Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By Content, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Pharmaceutical Fill and Finish Outsourcing Market

  • 24.1. USA Pharmaceutical Fill and Finish Outsourcing Market Overview
  • 24.2. USA Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By State Of Finished Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By Content, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Pharmaceutical Fill and Finish Outsourcing Market

  • 25.1. Canada Pharmaceutical Fill and Finish Outsourcing Market Overview
  • 25.2. Canada Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By State Of Finished Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By Content, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Pharmaceutical Fill and Finish Outsourcing Market

  • 26.1. South America Pharmaceutical Fill and Finish Outsourcing Market Overview
  • 26.2. South America Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By State Of Finished Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By Content, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Pharmaceutical Fill and Finish Outsourcing Market

  • 27.1. Brazil Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By State Of Finished Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By Content, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Pharmaceutical Fill and Finish Outsourcing Market

  • 28.1. Middle East Pharmaceutical Fill and Finish Outsourcing Market Overview
  • 28.2. Middle East Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By State Of Finished Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By Content, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Pharmaceutical Fill and Finish Outsourcing Market

  • 29.1. Africa Pharmaceutical Fill and Finish Outsourcing Market Overview
  • 29.2. Africa Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By State Of Finished Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By Content, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Pharmaceutical Fill and Finish Outsourcing Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Pharmaceutical Fill and Finish Outsourcing Market Competitive Landscape And Company Profiles

  • 30.1. Pharmaceutical Fill and Finish Outsourcing Market Competitive Landscape
  • 30.2. Pharmaceutical Fill and Finish Outsourcing Market Company Profiles
    • 30.2.1. Groninger and Co. GmbH
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Merck and Co. Inc.
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Abbott Laboratories
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Wockhardt Limited.
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Boehringer Ingelheim International GmbH
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Pharmaceutical Fill and Finish Outsourcing Market Other Major And Innovative Companies

  • 31.1. Becton Dickinson and Company
  • 31.2. AbbVie Inc.
  • 31.3. Teva Pharmaceuticals Industries Ltd.
  • 31.4. Recipharm AB.
  • 31.5. Lonza Group AG
  • 31.6. Catalent Inc.
  • 31.7. Dr. Reddys Laboratories Ltd.
  • 31.8. West Pharmaceutical Services Inc.
  • 31.9. Sun Pharmaceutical Industries Ltd.
  • 31.10. Patheon N.V.
  • 31.11. Piramal Enterprises Ltd.
  • 31.12. Gerresheimer AG
  • 31.13. CordenPharma International
  • 31.14. Fujifilm Diosynth Biotechnologies
  • 31.15. Optima Packaging Group GmbH

32. Global Pharmaceutical Fill and Finish Outsourcing Market Competitive Benchmarking

33. Global Pharmaceutical Fill and Finish Outsourcing Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Pharmaceutical Fill and Finish Outsourcing Market

35. Pharmaceutical Fill and Finish Outsourcing Market Future Outlook and Potential Analysis

  • 35.1 Pharmaceutical Fill and Finish Outsourcing Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Pharmaceutical Fill and Finish Outsourcing Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Pharmaceutical Fill and Finish Outsourcing Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer